Thermosensitive nanogels with multiple anti-tumour associated effects

Malou Henriksen-Lacey

CIC biomaGUNE

Dr. Malou Henriksen-Lacey is currently finishing her second postdoc in the group of Prof. Luis Liz-Marzán, who maintains an active research group in CICbiomaGUNE. Her interests are based on the use of nanoparticles and nanomaterials for drug delivery and sensing applications. She has experience with both radioactive and in vivo work dating from her PhD and first postdoc. Her present field of work focuses on the use of in vitro models to study the effects of different types of nanoparticles, specialising in imaging techniques including electron and fluorescence microscopy.

Abstract

Most chemotherapeutic treatments involve combination therapy to inhibit tumour growth, yet the systemic method of administration involving separate drug formulations results in undesirable side effects with a complicated... [ view full abstract ]

Authors

  1. Malou Henriksen-Lacey (CIC biomaGUNE)
  2. Malte Strozyk (University of Liverpool)
  3. Susana Carregal (CIC biomaGUNE)
  4. Mathias Brust (University of Liverpool)
  5. Luis Liz-Marzán (CIC biomaGUNE)

Topic Areas

Targeted drug delivery and Nanocarriers , Nanomedecine for cancer diagnosis & therapy

Session

OS1-025 » Targeted drug delivery and Nanocarriers - Nanomedecine for cancer diagnosis & therapy (16:00 - Wednesday, 28th September, Amphitheatre 25)

Presentation Files

The presenter has not uploaded any presentation files.